Lv7
3620 积分 2023-10-14 加入
Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability
7天前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
11天前
已关闭
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
11天前
已完结
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease
1个月前
已完结
Effect of resmetirom or placebo in NASH (MASH) fibrosis patients with<5% or≥5% weight loss and/or on baseline GLP-1 therapy in the MAESTRO-NASH 52-week serial liver biopsy study
1个月前
已关闭
Discovery and evaluation of SIPI11594: a novel mitochondrial pyruvate carrier inhibitor with anti-hair loss efficacy
2个月前
已完结
Design, synthesis and biological evaluation of novel cyano-cinnamate derivatives as mitochondrial pyruvate carrier inhibitors
2个月前
已完结
Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection
2个月前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
2个月前
已完结
Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat
2个月前
已关闭
皖公网安备34019202002308
